SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001469709-20-000049
Filing Date
2020-07-13
Accepted
2020-07-13 15:05:37
Documents
1
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5226
  Complete submission text file 0001469709-20-000049.txt   6610
Mailing Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017
Business Address 425 MADISON AVENUE, SUITE 902 NEW YORK NY 10017 212-874-6608
AngioGenex, Inc. (Issuer) CIK: 0001085596 (see all company filings)

IRS No.: 860945116 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 320 WEST MERMAID LANE PHILADELPHIA PA 19118
Business Address
Dickey Robert IV (Reporting) CIK: 0001466862 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-26181 | Film No.: 201025121